AHA Launches IMPLEMENT-Lipid Management Initiative

A three-year implementation science effort will bring 10 cardiology and primary care organizations together to improve cholesterol management.

Updated on Nov. 16, 2026 in Heart Disease

Bold vector editorial illustration of a glass test tube with pale amber liquid beside a stack of cream pill-shaped stones linked by a thin dark thread, in coral, teal, and sage.
The American Heart Association launched a three-year IMPLEMENT-Lipid Management initiative with 10 cardiology and primary care organizations to address barriers to cholesterol treatment, backed by Merck & Co. AI Illustration. Upload story photo >

Live Poll

Do you feel your doctor gives you enough help managing your cholesterol?

The American Heart Association has launched IMPLEMENT-Lipid Management, a three-year implementation science initiative bringing together 10 cardiology and primary care organizations in a national learning collaborative. The initiative is financially supported by Merck & Co., Inc.

Why it matters

The majority of people at risk for cardiovascular disease do not achieve recommended cholesterol levels. The initiative aims to identify practical barriers in clinical care that affect timely, guideline-directed treatment.

The initiative runs for three years across 10 participating cardiology and primary care organizations, including sites in North Dakota, California, Georgia, Florida, New York and Ohio. Specific cholesterol-control rates and expected improvement targets were not disclosed in the announcement.

The players

American Heart Association

The American Heart Association is a nonprofit organization focused on cardiovascular health research, education and advocacy in the United States and globally.

Merck & Co., Inc.

Merck & Co., Inc. is a global pharmaceutical company that develops and markets prescription medicines and vaccines.

The details

Participating organizations will analyze healthy lifestyle recommendations, treatment initiation and escalation pathways, referral practices, patient barriers, clinician workflows and care coordination processes. Participants will evaluate approaches through quality improvement consultation and peer-to-peer learning, with principal investigator Nishant Shah, M.D., leading the effort.

Timeline

  1. November 16, 2026: American Heart Association announces the launch of IMPLEMENT-Lipid Management.

  2. Three-year duration: the initiative runs for three years following its launch.

Heart Disease Care Gaps

The initiative extends the American Heart Association's outpatient quality improvement efforts into cholesterol management, with lessons from the collaborative intended to shape those future programs. It targets the gap between recommended cholesterol levels and what patients at cardiovascular risk actually achieve in routine primary and specialty care.

Patients at risk for cardiovascular disease may see changes in how cholesterol is managed in participating clinics as the initiative tests approaches to lifestyle guidance, treatment escalation and referrals. The collaborative's findings may eventually influence how primary care and cardiology offices handle prior authorization and follow-up care.

The takeaway

Cholesterol targets are only useful when care teams can reliably reach them, so workflow and referral barriers matter as much as drug choice. Patients at cardiovascular risk can ask their clinicians how their cholesterol goals are set and what follow-up steps are planned.

Further reading

Explore more coverage in the Heart Disease section for related cholesterol and cardiovascular care news.

More information

Learn more about the IMPLEMENT-Lipid Management initiative information from the American Heart Association.

Live Poll

Do you feel your doctor gives you enough help managing your cholesterol?